| . | No. (%)a . |
|---|---|
| Follow-up, mo, mean ± SD | 78.97 ± 41.019 |
| Elapsed time to sexual activity, wk, median (IQR) | 6 (5–7) |
| IIEF-5 score after the operation, median (IQR) | 22 (21–23) |
| Erectile dysfunction severity: IIEF-5 classification | |
| 22-25: no ED | 44 (75.9) |
| 17-21: mild | 5 (8.6) |
| 12-16: mild to moderate | 6 (10.3) |
| 8-11: moderate | 1 (1.7) |
| 5-7: severe | 2 (3.4) |
| Postoperative complications | |
| None | 31 (53.4) |
| Erectile dysfunction | 9 (15.4) |
| Penile curvature | 7 (12.1) |
| Palpable nodule | 8 (13.8) |
| Painful erection | 6 (10.3) |
| Paresthesia/numbness | 3 (5.2) |
| . | No. (%)a . |
|---|---|
| Follow-up, mo, mean ± SD | 78.97 ± 41.019 |
| Elapsed time to sexual activity, wk, median (IQR) | 6 (5–7) |
| IIEF-5 score after the operation, median (IQR) | 22 (21–23) |
| Erectile dysfunction severity: IIEF-5 classification | |
| 22-25: no ED | 44 (75.9) |
| 17-21: mild | 5 (8.6) |
| 12-16: mild to moderate | 6 (10.3) |
| 8-11: moderate | 1 (1.7) |
| 5-7: severe | 2 (3.4) |
| Postoperative complications | |
| None | 31 (53.4) |
| Erectile dysfunction | 9 (15.4) |
| Penile curvature | 7 (12.1) |
| Palpable nodule | 8 (13.8) |
| Painful erection | 6 (10.3) |
| Paresthesia/numbness | 3 (5.2) |
Abbreviations: ED, erectile dysfunction; IIEF-5, 5-item International Index of Erectile Function.
Data are presented as No. (%) unless noted otherwise.
| . | No. (%)a . |
|---|---|
| Follow-up, mo, mean ± SD | 78.97 ± 41.019 |
| Elapsed time to sexual activity, wk, median (IQR) | 6 (5–7) |
| IIEF-5 score after the operation, median (IQR) | 22 (21–23) |
| Erectile dysfunction severity: IIEF-5 classification | |
| 22-25: no ED | 44 (75.9) |
| 17-21: mild | 5 (8.6) |
| 12-16: mild to moderate | 6 (10.3) |
| 8-11: moderate | 1 (1.7) |
| 5-7: severe | 2 (3.4) |
| Postoperative complications | |
| None | 31 (53.4) |
| Erectile dysfunction | 9 (15.4) |
| Penile curvature | 7 (12.1) |
| Palpable nodule | 8 (13.8) |
| Painful erection | 6 (10.3) |
| Paresthesia/numbness | 3 (5.2) |
| . | No. (%)a . |
|---|---|
| Follow-up, mo, mean ± SD | 78.97 ± 41.019 |
| Elapsed time to sexual activity, wk, median (IQR) | 6 (5–7) |
| IIEF-5 score after the operation, median (IQR) | 22 (21–23) |
| Erectile dysfunction severity: IIEF-5 classification | |
| 22-25: no ED | 44 (75.9) |
| 17-21: mild | 5 (8.6) |
| 12-16: mild to moderate | 6 (10.3) |
| 8-11: moderate | 1 (1.7) |
| 5-7: severe | 2 (3.4) |
| Postoperative complications | |
| None | 31 (53.4) |
| Erectile dysfunction | 9 (15.4) |
| Penile curvature | 7 (12.1) |
| Palpable nodule | 8 (13.8) |
| Painful erection | 6 (10.3) |
| Paresthesia/numbness | 3 (5.2) |
Abbreviations: ED, erectile dysfunction; IIEF-5, 5-item International Index of Erectile Function.
Data are presented as No. (%) unless noted otherwise.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
